Conditions: Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 57
Healthy volunteers: no

Brief summary:
This study will determine if aspirin from PL2200, an investigational product, gets into the blood stream as quickly as enteric coated aspirin, and to test whether PL2200 is able to prevent blood clots as effectively as enteric coated aspirin, when administered to patients with diabetes

Detailed description:

Arms:
arm 1: PL2200 Aspirin Capsules arm 2: Enteric-coated aspirin caplets

Interventions: intervention 1: PL2200 Aspirin Capsules intervention 2: Enteric-coated aspirin caplets
Intervention descriptions: intervention 1: 325 mg aspirin; once per day for 10 days intervention 2: 325 mg aspirin; once per day for 10 days

Protocol document: